Dose Response Study of Aerobic Exercise in Older Adults

Alzheimer's Disease Clinical Trial

Official title:

Dose Response Study of Exercise for Age-related Cognitive Changes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01129115
• Other study ID #: 11883
• Status: Completed
• Phase: Phase 0
• First received: May 18, 2010
• Last updated: January 14, 2016
• Start date: May 2010
• Est. completion date: April 2014

Study information

• Verified date: January 2016
• Source: University of Kansas Medical Center
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

This is a randomized, 26-week study of supervised exercise assessing three doses of exercise in sedentary individuals 65 years of age and over with age-related cognitive changes. A total of 100 subjects (n=25 in each of four groups) will be randomized to a non-aerobic control group, 75 minutes, 150 minutes, or 225 minutes a week of moderate intensity aerobic exercise spread over 3 to 5 days a week for 26 weeks. These exercise doses represent 50%, 100%, or 150% of the recommended exercise dose. Participants will be directly supervised during all exercise sessions for the first two months after which direct supervision will occur during at least one session a week. This is intended to provide increased flexibility while also maintaining direct contact with the participant to enhance adherence. Aerobic fitness, physical function, and cognition will be assessed at baseline and 26 weeks to examine the dose-response relationships.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 101
• Est. completion date: April 2014
• Est. primary completion date: February 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

• Informed consent

• Age 65 years or older

• Underactive or sedentary based on the Telephone Assessment of Physical Activity

• Community dwelling with a caregiver willing to accompany the participant to visits to the screening evaluation. The caregiver must visit with the subject more than five times a week.

• Nondemented: Clinical Dementia Rating (CDR) 0

• Adequate visual and auditory abilities to perform all aspects of the cognitive and functional assessments

• Stable doses of medications for at least 30 days prior to screening.

• Likely to participate in all scheduled evaluations and complete the exercise program over 52 weeks

Exclusion Criteria:

• Dementia

• CDR > 0

• Current clinically significant major psychiatric disorder (e.g., Major Depressive Disorder) according to Diagnostic Statistical Manual (DSM)-IV criteria or Geriatric Depression score of 5 or greater.

• Significant psychiatric symptoms (e.g., hallucinations) that could impair the completion of the study

• Current clinically-significant systemic illness likely to result in deterioration of the patient's condition or affect the patient's safety during the study

• History of clinically-evident stroke

• Clinically-significant infection within the last 30 days

• Myocardial infarction or symptoms of coronary artery disease (e.g., angina) in the last two-years.

• Uncontrolled hypertension within the last 6 months

• History of cancer within the last 5 years (except non-metastatic basal or squamous cell carcinoma)

• History of drug or alcohol abuse as defined by DSM-IV criteria within the last 2 years

• Insulin-dependent diabetes mellitus

• Significant pain or musculoskeletal disorder that would prohibit participation in an exercise program

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Alzheimer Disease
• Alzheimer's Disease

Intervention

Behavioral:
• Nonexercise control group
Participants randomized to the nonexercise control group will be asked to maintain their current level of physical activity during the 26-week active study period. They will perform outcome assessments and receive the same telephone checks as the exercise group at baseline, 26 and 52 weeks. The purpose of including a non-exercise control group is to allow adequate comparisons with the low, medium and high exercise dose groups on changes in cognitive and physiologic outcome measures.
• Aerobic Exercise Group 1
The 50% group will perform 75 minutes a week of moderate intensity exercise spread over 3 days.
• Aerobic Exercise Group 2
The 100% group will perform 150 minutes a week of exercise over 3 - 5 days
• Aerobic Exercise Group 3
The 150% group will perform 225 minutes a week of exercise over 4 - 5 days.

Locations

Country	Name	City	State
United States	University of Kansas Medical Center	Kansas City	Kansas

Sponsors (1)

Lead Sponsor	Collaborator
Jeff Burns, MD

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visuospatial Processing	Visuospatial Processing is a latent derived variable derived estimated mean.The reported latent means for this trial are created from the well-known neuropsychological tests: Block Design, Stroop Color Reading, Digit Symbol Substitution and Trailmaking Test A.; Latent variables cannot be measured directly but are derived from a theory-driven confirmatory factor analysis in a structural equation model framework. The latent scores are centered around a mean of 0 and standardized so each value represents a fraction of the standard deviation. There are no limits to the scores. Positive number indicate improved performance. Negative numbers indicate worsening performance.	26 weeks	No
Primary	Change in Maximal Oxygen Consumption	Maximal Oxygen consumption (VO2 max) is the standard, quantitative measure of aerobic fitness. The physiologic range of scores is approximately 3.5 milliliters of oxygen per kilogram of body weight per minute (ml/kg/min) to approximately 90 (ml/kg/min). Higher numbers indicate greater fitness and positive change indicates increasing fitness. Lower number indicate worse fitness	26 weeks	No
Primary	Change in Physical Performance Test	The Physical Performance Test is a 9-item measure of physical function. The range of scores is 0-34. Higher numbers indicate better physical function. Positive change indicates improving function. Negative change indicates decreasing function.	26 Week	No
Secondary	Verbal Memory	Verbal Memory is a latent derived variable derived estimated mean. The reported latent means for this trial are created from the well-known neuropsychological tests: Logical Memory, Delayed Logical Memory, Selective Reminding Task - Free Recall Total, Boston Naming Test.; Latent variables cannot be measured directly but are derived from a theory-driven confirmatory factor analysis in a structural equation model framework. The latent scores are centered around a mean of 0 and standardized so each value represents a fraction of the standard deviation. There are no limits to the scores. Positive number indicate improved performance.Negative numbers indicate worsening performance.	26 weeks	No
Secondary	Simple Attention	Simple Attention is a latent derived variable derived estimated mean. The reported latent means for this trial are created from the well-known neuropsychological tests: Digit span Forward and Backward, Letter Numbers Sequencing.; Latent variables cannot be measured directly but are derived from a theory-driven confirmatory factor analysis in a structural equation model framework. The latent scores are centered around a mean of 0 and standardized so each value represents a fraction of the standard deviation. There are no limits to the scores. Positive number indicate improved performance. Negative numbers indicate worsening performance.	26 Weeks	No
Secondary	Set Maintenance & Shifting	Set Maintenance and Switching is a latent derived variable derived estimated mean. The reported latent means for this trial are created from the well-known neuropsychological tests: DKEFS Card Sort, Animal and Vegetable Category Fluency.; Latent variables cannot be measured directly but are derived from a theory-driven confirmatory factor analysis in a structural equation model framework. The latent scores are centered around a mean of 0 and standardized so each value represents a fraction of the standard deviation. There are no limits to the scores. Positive number indicate improved performance. Negative numbers indicate worsening performance.	26 Weeks	No
Secondary	Reasoning	Reasoning is a latent derived variable derived estimated mean. The reported latent means for this trial are created from the well-known neuropsychological tests:Letter and Word Inductive Reasoning, Matrix Reasoning.; Latent variables cannot be measured directly but are derived from a theory-driven confirmatory factor analysis in a structural equation model framework. The latent scores are centered around a mean of 0 and standardized so each value represents a fraction of the standard deviation. There are no limits to the scores. Positive number indicate improved performance. Negative numbers indicate worsening performance.	26 Weeks	No